Company: PTHS
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001753926-25-001606
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-10-14
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item
7.01. Regulation FD Disclosure.

On October 14, 2025, Pelthos Therapeutics Inc. (the “ Company”) made available a presentation
on its website. A copy of the presentation is attached hereto as Exhibit 99.1. Information contained on the Company’s website is
not incorporated by reference into and should not be considered to be part of this Current Report on Form 8-K.

The information contained
in this Item 7.01, including Exhibit 99.1 attached hereto, which is incorporated into this Item 7.01 by reference, is being furnished
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended (the “ Securities Act”), or the Exchange Act, except as expressly set forth by
specific reference in such filing. The information set forth in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed an
admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy
the requirements of Regulation FD.

Forward-Looking
Statements